Author: Dale HewettImportant: This article is for educational purposes only and is not medical advice. Diabetes is a serious chronic disease that should be managed by a primary-care provider, endocrinologist, or diabetes care team. Shilajit is not approved by the FDA to treat diabetes. Never replace prescribed insulin or oral diabetes medications with a supplement.
Shilajit is a sticky, mineral-rich substance that exudes from rocks in mountain regions of the Himalayas and other high-altitude environments. It has a long traditional-medicine history and a small modern research base. Because diabetes is so common, shilajit-and-diabetes is a frequent question. The honest answer is that shilajit is not a diabetes treatment and standard diabetes care is what controls long-term outcomes.
The short version
- Shilajit is not a treatment for diabetes. No shilajit product is FDA-approved for Type 1 diabetes, Type 2 diabetes, prediabetes, or any diabetes complication.
- The clinical research on shilajit specifically in human diabetes patients is very limited. Most published work is preclinical (animal-model studies of fulvic-acid components and metabolic pathways).
- Standard diabetes care includes glycemic monitoring, prescribed medications matched to type and patient profile (insulin for Type 1; metformin, GLP-1 receptor agonists, SGLT-2 inhibitors and others for Type 2), nutrition support, and physical activity. These have decades of evidence behind them.
What shilajit actually is
Shilajit is a substance that forms over centuries from compressed plant and microbial material in high-altitude rock formations. It is dark, sticky, and rich in fulvic acid, humic acid, dibenzo-α-pyrones, and trace minerals. Traditional Ayurvedic and Tibetan medicine have used it for centuries.
Modern interest in shilajit has focused on its fulvic-acid content and antioxidant properties. A small clinical research base has examined its effects on testosterone in men, exercise performance, and a few other endpoints. Quality varies considerably across products, and adulteration with heavy metals or non-shilajit fillers has been documented in independent testing.
What shilajit-and-diabetes research has actually examined
The published evidence specific to shilajit in human diabetes is sparse:
- Some preclinical animal-model studies have examined effects on blood glucose, insulin sensitivity, and pancreatic-islet biology. Results are mixed.
- A few small human studies have included metabolic markers as secondary outcomes. Findings have not been replicated at scale.
- Fulvic acid components have been studied in broader metabolic contexts, with very preliminary findings.
There is no large randomized controlled trial of shilajit specifically for diabetes that supports a treatment claim.
What evidence-based diabetes care actually looks like
For Type 1 diabetes: lifelong insulin therapy is essential, often with continuous glucose monitoring and insulin pump therapy. Care is led by an endocrinologist.
For Type 2 diabetes:
- Glycemic monitoring with HbA1c and individualized targets
- Metformin as first-line for most patients
- GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) — substantial efficacy and now standard for many patients, particularly those with cardiovascular disease or obesity
- SGLT-2 inhibitors (empagliflozin, dapagliflozin, others) — particularly useful in patients with heart failure or kidney disease
- Other agents: DPP-4 inhibitors, sulfonylureas, thiazolidinediones, insulin when needed
- Nutrition support with a registered dietitian
- Physical activity — meaningful effect on insulin sensitivity
- Weight management when appropriate — substantial weight loss can produce remission of Type 2 diabetes in some patients
Quality concerns specific to shilajit
A practical note: independent testing of shilajit products has periodically found heavy-metal contamination (lead, arsenic, mercury) above acceptable limits, and adulteration with non-shilajit fillers. If you choose to use a shilajit product, look for:
- Third-party testing including heavy metals
- Specified fulvic-acid content
- Sourcing transparency
This applies regardless of intended use, but matters more when chronic use is being considered.
Drug-interaction considerations
Shilajit’s interaction profile with diabetes medications is not well characterized. Discuss any supplement use with the prescribing clinician. Patients on insulin or insulin secretagogues need predictable medication effects, and adding any supplement that could affect glucose handling creates uncertainty.
What the FDA has said
The FDA has not approved any shilajit product for diabetes or any disease. Like all dietary supplements, shilajit products are regulated under DSHEA and cannot be marketed with disease-treatment claims.
Talking to your endocrinologist or primary-care provider
If you have diabetes and are curious about shilajit as part of a broader wellness routine, useful questions:
- Are my current targets (HbA1c, blood pressure, lipids) being met?
- Is my regimen optimized — have I tried GLP-1 receptor agonists or SGLT-2 inhibitors if appropriate?
- If I do try a shilajit product, should I monitor my blood sugar more closely for a period, and should you know about quality concerns with shilajit products?
What we offer at New Phase Blends
We make third-party-tested shilajit and other supplement products designed for general wellness use. They are not formulated, tested, or marketed as treatments for diabetes or any metabolic disease. If you have diabetes, please continue to follow the plan your diabetes care team has built for you.
Frequently asked questions
Does shilajit lower blood sugar? There is no clinical evidence that consumer shilajit products produce meaningful improvements in glycemic control in human diabetes.
Can I stop my diabetes medication if I take shilajit? No. Stopping prescribed diabetes medication, especially insulin in Type 1 diabetes, can be life-threatening.
What about new diabetes medications like semaglutide? GLP-1 receptor agonists have produced substantial improvements in glycemic control and weight in clinical trials and have changed Type 2 diabetes care considerably. They are prescription medications and should be discussed with a clinician.
Is shilajit safe? Quality varies considerably. Heavy-metal contamination has been documented in some products. Third-party testing matters.
Disclaimer: The statements made on this page have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease, including diabetes. The information here is for educational purposes only and is not a substitute for advice from a licensed medical professional.
